DE60000969D1 - Pyrrolobenzodiazepine carboxamide vasopressin agonisten - Google Patents

Pyrrolobenzodiazepine carboxamide vasopressin agonisten

Info

Publication number
DE60000969D1
DE60000969D1 DE60000969T DE60000969T DE60000969D1 DE 60000969 D1 DE60000969 D1 DE 60000969D1 DE 60000969 T DE60000969 T DE 60000969T DE 60000969 T DE60000969 T DE 60000969T DE 60000969 D1 DE60000969 D1 DE 60000969D1
Authority
DE
Germany
Prior art keywords
hydrogen
chain alkyl
branched chain
alkoxyalkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60000969T
Other languages
English (en)
Inventor
John Steffan
Arturo Failli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of DE60000969D1 publication Critical patent/DE60000969D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60000969T 1999-02-04 2000-01-11 Pyrrolobenzodiazepine carboxamide vasopressin agonisten Expired - Lifetime DE60000969D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24418099A 1999-02-04 1999-02-04
PCT/US2000/000658 WO2000046228A2 (en) 1999-02-04 2000-01-11 Pyrrolobenzodiazepine carboxyamide vasopressin agonists

Publications (1)

Publication Number Publication Date
DE60000969D1 true DE60000969D1 (de) 2003-01-23

Family

ID=22921685

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60000969T Expired - Lifetime DE60000969D1 (de) 1999-02-04 2000-01-11 Pyrrolobenzodiazepine carboxamide vasopressin agonisten

Country Status (8)

Country Link
EP (1) EP1149104B1 (de)
JP (1) JP2002536378A (de)
CN (1) CN1339037A (de)
AT (1) ATE229528T1 (de)
AU (1) AU2607300A (de)
CA (1) CA2358892A1 (de)
DE (1) DE60000969D1 (de)
WO (1) WO2000046228A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
CN103420890B (zh) * 2012-05-15 2015-06-24 天津药物研究院 3-吡咯甲酸衍生物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

Also Published As

Publication number Publication date
WO2000046228A3 (en) 2000-12-14
JP2002536378A (ja) 2002-10-29
EP1149104A2 (de) 2001-10-31
AU2607300A (en) 2000-08-25
EP1149104B1 (de) 2002-12-11
ATE229528T1 (de) 2002-12-15
CA2358892A1 (en) 2000-08-10
WO2000046228A2 (en) 2000-08-10
CN1339037A (zh) 2002-03-06

Similar Documents

Publication Publication Date Title
SG159380A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
NO20000242D0 (no) Tricykliske vasopressin agonister
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
TW200800938A (en) Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism
MA30412B1 (fr) Composés Pharmaceutiques
WO2007095174A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
TW200607807A (en) Macrocyclic beta-secretase inhibitors
LU91761I2 (fr) Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®)
TW200744587A (en) Azaindole derivatives exhibiting PGD2 receptor antagonism
WO2006113552A3 (en) Cyanoarylamines
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
EA015971B1 (ru) Терапевтическое средство против глаукомы, содержащее в качестве активного ингредиента производное аденозина
HK1061645A1 (en) 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
ATE548042T1 (de) Prostansäurederivate zur senkung des augeninnendrucks
WO2002100388A3 (en) Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
DE60000969D1 (de) Pyrrolobenzodiazepine carboxamide vasopressin agonisten
ATE277926T1 (de) Trizyclische vasopressin agoniste
MXPA03009159A (es) Ciclohexilfenilos agonistas de vasopresina.
KR970702273A (ko) 인돌 유도체 및 이를 함유하는 제제(indole derivative and medicine containing the same)
RU2004103079A (ru) Новые иммуномодулирующие соединения
ATE511506T1 (de) Thiopen-derivate als wirkstoffe gegen okulare hypotonie
MXPA04002496A (es) Composicion farmaceutica para el tratamiento de enfermedades urinarias.
SE0103858D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
8332 No legal effect for de